<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurochem Res</journal-id><journal-id journal-id-type="iso-abbrev">Neurochem Res</journal-id><journal-title-group><journal-title>Neurochemical Research</journal-title></journal-title-group><issn pub-type="ppub">0364-3190</issn><issn pub-type="epub">1573-6903</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39652154</article-id><article-id pub-id-type="pmc">PMC11628441</article-id>
<article-id pub-id-type="publisher-id">4306</article-id><article-id pub-id-type="doi">10.1007/s11064-024-04306-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Physiological and Pathological Role of mTOR Signaling in Astrocytes</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7633-9869</contrib-id><name><surname>Hochmuth</surname><given-names>Luise</given-names></name><address><email>luise.hochmuth@medizin.uni-leipzig.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6327-0089</contrib-id><name><surname>Hirrlinger</surname><given-names>Johannes</given-names></name><address><email>johannes.hirrlinger@medizin.uni-leipzig.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03s7gtk40</institution-id><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>Carl-Ludwig-Institute for Physiology, Faculty of Medicine, </institution><institution>University of Leipzig, </institution></institution-wrap>D- 04103 Leipzig, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03av75f26</institution-id><institution>Department of Neurogenetics, </institution><institution>Max-Planck-Institute for Multidisciplinary Sciences, </institution></institution-wrap>D- 37075 G&#x000f6;ttingen, Germany </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>50</volume><issue>1</issue><elocation-id>53</elocation-id><history><date date-type="received"><day>6</day><month>9</month><year>2024</year></date><date date-type="rev-recd"><day>20</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>2</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The mammalian target of rapamycin (mTOR) signaling pathway is one of the key regulators of cellular energy metabolism. It senses diverse alterations in the extracellular environment such as availability of nutrients and growth factors, and mediates the corresponding intracellular response. In the brain, astrocytes crucially contribute to energy and neurotransmitter metabolism, and numerous other functions. However, the relevance of physiological, astrocytic mTOR signaling in maintaining brain homeostasis and function is not well understood. Pathophysiological mTOR signaling is involved in manifold diseases in the central nervous system and most of the knowledge about astrocytic mTOR signaling has been derived from observations on these disorders. Dysregulation of the mTOR signaling pathway impairs important functions of astrocytes including neurotransmitter uptake and -signaling as well as energy metabolism. Some of these alterations could trigger neuropathological conditions such as epilepsy. This review focuses on how mTOR signaling regulates properties of astrocytes, and how these signaling events might contribute to the physiological function of the brain.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>mTOR</kwd><kwd>Astrocyte</kwd><kwd>Glutamate</kwd><kwd>Mitochondria</kwd></kwd-group><funding-group><award-group><funding-source><institution>Universit&#x000e4;t Leipzig (1039)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Astrocytes are a type of glial cells in the central nervous system (CNS), which contribute to many functions of the brain including the maintenance of energy homeostasis, synaptogenesis, the regulation of the blood-brain-barrier, learning processes, control of behavior, and others [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. Astrocytes form neuron-glia assemblies with their interaction partners in the local circuitry. They are recognized as a highly heterogeneous cell population, differing in morphology, metabolism, and function depending on their location in the brain, but also during different disease states [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. Therefore, it is hardly surprising that disturbances in astrocytes&#x02019; function, and specifically astrocyte metabolism, are associated with a variety of brain pathologies.</p><p id="Par3">The metabolism of astrocytes and neurons is interconnected with both types of cells expressing specific metabolic properties [<xref ref-type="bibr" rid="CR13">13</xref>]. Glucose, provided by the blood, is the main energy substrate for the brain. Astrocytes and neurons can take up glucose from the extracellular space via glucose transporter 1 (GLUT1) and GLUT3, respectively [<xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref>]. In astrocytes, glucose can be metabolized via glycolysis, the pentose phosphate pathway (PPP) or stored as glycogen [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. While there is an ongoing debate, whether lactate produced by astrocytes is essential for covering neuronal energy requirements [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref>], there is evidence that astrocytic lactate production is modulated by adrenergic, purinergic and endocannabinoid signaling and contributes to memory formation [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>]. In astrocytes, pyruvate produced during glycolysis is transported into mitochondria and undergoes oxidative decarboxylation thereby fueling mitochondrial ATP production [<xref ref-type="bibr" rid="CR13">13</xref>]. In addition, astrocytes express pyruvate carboxylase, a mitochondrial enzyme catalyzing the anaplerotic reaction from pyruvate to oxaloacetate [<xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>]. Furthermore, astrocytes release glutathione to support neuronal antioxidative defense [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Another important aspect of astrocytic metabolism is the glutamate/&#x003b3;-aminobutyric acid (GABA)-glutamine cycle [<xref ref-type="bibr" rid="CR31">31</xref>]. Astrocytes take up glutamate via excitatory amino acid transporters (EAAT1, also called GLAST) and EAAT2 (also called Glt-1) and recycle it back to neurons as glutamine. Glutamine is also used by GABAergic neurons as precursor for GABA, while GABA released from these neurons can be taken up and metabolized by astrocytes [<xref ref-type="bibr" rid="CR32">32</xref>]. Furthermore, glutamate is an important gliotransmitter released by astrocytes to signal to neurons, thereby, for instance, influencing synaptic efficiency, plasticity, the synchronization of neurons, neural circuit activity and network states [<xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>]. Therefore, as disturbances in astrocytic metabolism can have far-reaching consequences for the CNS, there needs to be a tight control and regulation of astrocytic metabolism in the context of the local neuron-glia assemblies.</p><p id="Par4">The mammalian target of rapamycin (mTOR) signaling pathway is a crucial mediator between nutritional signals and an appropriate cellular response, which regulates cell survival, autophagy and metabolism. mTOR is a serine/threonine protein kinase that constitutes the catalytic subunit of two distinct protein complexes. mTOR complex 1 (mTORC1) consists of the proteins mTOR, regulatory protein associated with mTOR (Raptor), and mammalian lethal with Sec13 protein 8 (mLST8), among others, and is responsible for regulating cell growth according to nutritional signals such as oxygen, energy, amino acids and stress [<xref ref-type="bibr" rid="CR37">37</xref>]. mTORC1 regulates protein synthesis, protein degradation, autophagy, as well as glucose, lipid, amino acid and nucleotide metabolism [<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref>]. Important downstream targets of mTORC1 are p70S6 Kinase 1 (S6K1) and eIF4E Binding Protein (4EBP) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Furthermore, transcription factors including activating transcription factor 4 (ATF4), sterol regulatory element binding protein (SREBP), and hypoxia inducible factor 1, &#x003b1;-subunit (HIF1&#x003b1;), are targets of regulation by mTORC1 [<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref>]. In contrast to mTORC1, mTOR complex 2 (mTORC2) consists of mTOR, mLST8, and rapamycin insensitive companion of mTOR (Rictor), among others [<xref ref-type="bibr" rid="CR41">41</xref>]. Therefore, it is hardly affected by the common mTORC1 inhibitor rapamycin. mTORC2 is mainly activated by growth factors and regulates cell proliferation and survival through phosphorylation of protein kinase B (Akt) and several members of the AGC family of protein kinases (protein kinase A, G, and C; PKA/PKG/PKC) [<xref ref-type="bibr" rid="CR38">38</xref>]. An important upstream regulator of mTORC1 signaling are the tuberous sclerosis complexes 1 (TSC1) and 2, which inhibit the activity of mTORC1 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). A detailed description of the highly complex signaling network involving mTORC1 and mTORC2 is beyond the scope of this review; but can be found in recent reviews [<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref>].</p><p id="Par5">
<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>The mTOR signaling pathway in astrocytes (simplified scheme).</bold> mTOR is activated by a signaling cascade which includes positive and negative regulators. Downstream of mTOR, important targets like 4EBP and the kinase S6K1 are activated. Black arrows indicate activation, while red T-shaped lines indicate inhibitory interactions. 4EBP - eIF4E Binding Protein, Akt - Protein kinase B, D-2-HG - D-2-Hydroxyglutarate, HABP2 - Hyaluronan-binding protein 2, IDH&#x02013; Isocitrate dehydrogenase, InsR&#x02013; Insulin receptor, mTORC1&#x02013; mammalian target of rapamycin complex 1, Mut - mutation, PAR1 - Protease-activated receptor 1, PI3K - Phosphoinositide 3-kinase, PTEN - Phosphatase and tensin homolog, Rheb - Ras homolog enriched in brain, RTKs - Receptor tyrosine kinases, S6K1 - Ribosomal protein S6 kinase beta-1, TSC1/2 - Tuberous sclerosis complex 1 / 2. Created in BioRender. Hirrlinger, J. (2024) <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/a64w464">https://BioRender.com/a64w464</ext-link></p></caption><graphic xlink:href="11064_2024_4306_Fig1_HTML" id="d33e325"/></fig>
</p><p id="Par6">Although mTOR is well known as key regulator of energy metabolism, its contribution to the control of carbohydrate metabolism is not completely understood [<xref ref-type="bibr" rid="CR39">39</xref>]. It is assumed that both mTOR complexes can detect glucose levels [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Chronic mTORC1 inhibition by rapamycin, as well as the disruption of mTORC2 in various tissues, leads to insulin resistance [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR44">44</xref>&#x02013;<xref ref-type="bibr" rid="CR46">46</xref>]. Hyperactivation of the mTOR signaling pathway via inhibition of the TSC1/2 complexes alters the expression of glucose-6-phosphate dehydrogenase (G6PD) and GLUT1 [<xref ref-type="bibr" rid="CR47">47</xref>]. Furthermore, both mTOR complexes control the carbon flux into the PPP mainly by increased expression of G6PD and ribose-5-phosphate isomerase A (regulated by mTORC1) as well as by phosphorylation of transketolase via protein kinase B (AKT; regulated by mTORC2) [<xref ref-type="bibr" rid="CR47">47</xref>&#x02013;<xref ref-type="bibr" rid="CR49">49</xref>]. The mTOR signaling pathway thereby controls the production of NADPH, purines, and pyrimidines, which are important for lipid and nucleic acid synthesis and thus also influences cell proliferation [<xref ref-type="bibr" rid="CR39">39</xref>]. Another important aspect of mTOR signaling is the regulation of protein synthesis and amino acid metabolism. Activation of the mTOR downstream targets 4EBP and the kinase S6K1 cause the phosphorylation of various eukaryotic initiation factors, which play a key role during translation initiation [<xref ref-type="bibr" rid="CR50">50</xref>&#x02013;<xref ref-type="bibr" rid="CR52">52</xref>]. Furthermore, inhibition of mTORC1 downregulates the expression of asparagine synthetase and neutral amino acid transporters, while inhibition of mTORC2 enhances the release of glutamate and cysteine uptake [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>].</p><p id="Par7">Dysregulation of the mTOR signaling pathway has serious consequences for cell and tissue homeostasis and contributes decisively to a variety of diseases in the CNS. Neurological disorders caused by genetic defects within the mTOR pathway are called mTORopathies and are characterized by malformations in the cerebral cortex, epileptogenesis, cognitive impairment and autism [<xref ref-type="bibr" rid="CR55">55</xref>]. mTOR hyperactivation is a common feature of several brain diseases and correlates with the severity of the diseases [<xref ref-type="bibr" rid="CR56">56</xref>]. For instance, tuberous sclerosis complex (TSC) is a typical mTORopathy, which is caused by loss of function mutations of TSC1 or TSC2 resulting in hyperactivation of the mTOR signaling cascade (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Furthermore, dysregulated mTOR activity promotes tumor growth of subependymal giant cell astrocytomas (SEGAs) in TSC as well as in cells from glioblastoma multiforme (GBM) [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>].</p></sec><sec id="Sec2"><title>Mechanisms and Effects of mTOR (over-) Activation in Astrocytes</title><p id="Par8">Important insights in the function and relevance of mTOR signaling has been obtained in conditions with dysregulation of this signaling pathway in astrocytes, which can result from a variety of changes within the regulatory cascade and from peripheral influences. In the context of ischemic stroke, peripheral blood-derived exosomes containing hyaluronan-binding protein 2 (HABP2) promote the expression of protease-activated receptors 1 (PAR1) in astrocytes causing activation of the phosphoinositide 3-kinase (PI3K) / AKT / mTOR pathway (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR60">60</xref>]. Another molecule that is upregulated in astrocytes and neurons during ischemic strokes is SerpinA3N, which induces increased phosphorylation of AKT and mTOR in vitro and in vivo [<xref ref-type="bibr" rid="CR61">61</xref>].</p><p id="Par9">Furthermore, the mTOR signaling pathway plays an important role during embryonic development [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. It is therefore not surprising that disturbances in this signaling pathway affect brain development and cell maturation. In the disease TSC, mutations of TSC1 or TSC2 result in loss of TSC1/2 function and, thereby, hyperactivation of mTOR signaling (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). This genetic dysregulation of mTOR signaling causes changes of the structure of the whole brain, as well as of the cellular morphology of both neurons and astrocytes. During cortical development, focal lesions, called &#x0201c;tubers&#x0201d;, are formed in TSC brains, which are characterized by cortical dyslamination and the presence of different types of (diseased) cells, like dysmorphic neurons, giant cells as well as reactive astrocytes. Furthermore, patients develop SEGAs and epilepsy [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR64">64</xref>&#x02013;<xref ref-type="bibr" rid="CR66">66</xref>]. The activation of mTOR also alters the morphology and function of astrocytes so that they phenotypically resemble an immature cell type [<xref ref-type="bibr" rid="CR67">67</xref>], characterized as large and vimentin positive cells, which express high GluR4/GluR2 and high NR2A/NR2C ratios in their &#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid type glutamate receptors (AMPAR), and N-methyl-D-aspartate type glutamate receptors (NMDAR), respectively [<xref ref-type="bibr" rid="CR68">68</xref>&#x02013;<xref ref-type="bibr" rid="CR70">70</xref>].</p><p id="Par10">Additional insight on potential regulatory mechanisms affected by mTOR signaling in the brain is provided by observations on brain tumors, like GBM, which is one of the most common and most severe brain cancer types [<xref ref-type="bibr" rid="CR71">71</xref>]. It has to be noted that GBMs are highly heterogenous regarding many aspects, including genetic mutations, expression levels of tumor associated genes, as well as cell composition, containing cells with astrocytic, oligodendrocytic, neural progenitor, and mesenchymal features [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. Therefore, observations on GBM cannot be directly extrapolated on physiological functions of mTOR signaling in astrocytes, but may only hint to potential functions. In many cases of GBM, an increased activity of mTOR signaling results in elevated cell proliferation and cell survival, with a simultaneous reduction in apoptosis, thereby promoting tumorigenesis and treatment resistance [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. However, the causes of PI3K / AKT / mTOR pathway hyperactivation in the context of GBM are manifold. Various mutations such as loss of function mutations of the tumor suppressor &#x0201c;phosphatase and tensin homolog&#x0201d; (PTEN), which acts as a negative regulator of PI3K, or mutations of receptor tyrosine kinases such as platelet-derived growth factor receptor (PDGFR) and epidermal growth factor receptor (EGFR), can result in permanent activation of PI3K, an upstream positive regulator of mTOR (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. In addition, in some gliomas an activating mutation of isocitrate dehydrogenase (IDH) results in overproduction of (D)-2-hydroxyglutarate (D-2-HG), which activates mTOR signaling [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>].</p><p id="Par11">In summary, various factors are known to induce activation of the mTOR signaling pathway in astrocytes. However, also other, so far unknown, mechanisms most likely result in dysregulated mTOR signaling in the context of neurological disorders. Furthermore, much less is known about the physiological regulation, activation, and relevance of this crucial signaling pathway in the healthy brain.</p></sec><sec id="Sec3"><title>mTOR Signaling Regulates Astrocytic Neurotransmitter Signaling and Metabolism</title><p id="Par12">Activation of mTOR signaling, in particular increased phosphorylation of S6K1, alters the expression and composition of various receptors and transporters involved in glutamate signaling. It reduces the expression of the glutamate transporters EAAT1 and EAAT2 in astrocytes (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>), restraining glutamate clearance from the synaptic cleft [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR77">77</xref>&#x02013;<xref ref-type="bibr" rid="CR79">79</xref>]. This downregulation can be reversed by the mTOR inhibitor rapamycin, which blocks the phosphorylation and activation of S6K1. Consistently, in human TSC derived astrocytes a decreased expression of EAAT1, EAAT2, glutamine synthetase (GS) and the GluR1 subunit of AMPARs was described; however, activation of S6K1 was not directly confirmed [<xref ref-type="bibr" rid="CR67">67</xref>]. Vice versa, rapamycin increases the expression of EAAT2 in TSC1 knockout and control mice, thereby reducing extracellular glutamate levels [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. Astrocytes from human cortical TSC tissue express AMPA- and NMDA-glutamate receptors with subunit compositions typical for immature astrocytes from midgestational brains (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) [<xref ref-type="bibr" rid="CR69">69</xref>]. Furthermore, different subtypes of astrocytes were described in TSC patients, which differ greatly in terms of mTOR activation, morphology and expression patterns [<xref ref-type="bibr" rid="CR69">69</xref>]. However, whether these effects are a direct consequence of mTOR dysregulation in the astrocyte itself, or whether mTOR activation in other types of cells, e.g. neurons, induce signals which then affect astrocytes has not been unequivocally resolved yet and remains to be determined for many cases.</p><p id="Par13">
<fig id="Fig2"><label>Fig. 2</label><caption><p><bold>Effects of activated mTOR signaling in astrocytes.</bold> Black arrows show alterations due to increased phosphorylation of S6K1 or which are reversible using rapamycin. Red dashed arrows show alterations in astrocytes derived from TSC tissue. Asterisks show changes in receptor composition due to activated mTOR signaling. AMPAR - &#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, Cx43 - connexin 43, EAAT - excitatory amino acid transporter, GLS&#x02013; Glutaminase, GS - Glutamine synthetase, NMDAR - N-methyl-D-aspartate receptor. Created in BioRender. Hirrlinger, J. (2024) <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/z22t421">https://BioRender.com/z22t421</ext-link></p></caption><graphic xlink:href="11064_2024_4306_Fig2_HTML" id="d33e520"/></fig>
</p><p id="Par14">In addition to glutamate uptake and glutamate receptor signaling, mTOR also influences potassium clearance by downregulating the expression of the astrocytic gap junction protein connexin 43 (Cx43), thereby affecting astrocytic gap junction coupling (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) [<xref ref-type="bibr" rid="CR81">81</xref>]. In mice with genetic deletion of Tsc1 in astrocytes, Cx43 expression is reduced, resulting in increased extracellular concentration of potassium. This phenotype is reversed by treatment with rapamycin, suggesting that it is caused by activation of mTOR signaling [<xref ref-type="bibr" rid="CR81">81</xref>].</p><p id="Par15">Using astrocytes derived from human TSC patients, an impact of the mTOR pathway on astrocytic calcium signaling and mitochondrial metabolism was suggested (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>); however, mTOR activation or S6K1 phosphorylation was not directly confirmed in these astrocytes, but assumed from the TSC mutations [<xref ref-type="bibr" rid="CR82">82</xref>]. This study showed transcriptomic and proteomic alterations in signaling pathways involved in calcium regulation, calcium-dependent neurotransmitter signaling, cellular respiration and mitochondrial metabolism [<xref ref-type="bibr" rid="CR82">82</xref>]. Furthermore, cultured primary astrocytes from TSC patients exhibit lower calcium uptake and release as well as decreased basal cytosolic and mitochondrial calcium levels [<xref ref-type="bibr" rid="CR82">82</xref>]. Mitochondrial dysfunction in TSC astrocytes was characterized by depolarization of mitochondrial membrane potential, decreased calcium exchange, reduced respiratory capacity and oxygen consumption rate as well as altered mitochondrial morphology, including mitochondrial fragmentation and structural remodeling of mitochondria [<xref ref-type="bibr" rid="CR82">82</xref>]. Whether these observations reflect physiological regulations of astrocytic metabolism by mTOR or are caused by long-term adaptations to the genetic defect in TSC astrocytes remains to be established.</p><p id="Par16">In summary, in astrocytes, mTOR signaling affects several aspects of glutamate signaling, synaptic glutamate clearance, glutamate metabolism, potassium buffering, calcium signaling as well as mitochondrial metabolism (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Dysregulation of these functions of astrocytes by pathological activation of mTOR could explain the epileptogenesis in several diseases associated with impaired mTOR signaling. However, it has been discussed whether seizures are a result of mTOR activation or if they induce mTOR activity [<xref ref-type="bibr" rid="CR70">70</xref>]. While in a kainic acid seizure mouse model evidence has been obtained indicating seizures promote mTOR activity [<xref ref-type="bibr" rid="CR83">83</xref>], induction of seizures by mTOR dysregulation is also a likely scenario. Therefore, further studies on the impact of astrocytic mTOR signaling in synaptic function are needed and could pave the way for identifying new targets for therapies against epilepsy.</p></sec><sec id="Sec4"><title>Mutual Influence of mTOR Activity between Astrocytes and Neurons</title><p id="Par17">As described above, numerous studies provide evidence for the function and relevance of mTOR signaling in astrocytes. However, the brain is a complex organ with a complex interplay of various cell types including astrocytes, neurons, oligodendrocytes, microglial cells, pericytes, endothelial cells and others. Most likely, all of these cell types use the mTOR signaling pathway for their own needs with cell type-specific properties. Therefore, in some scenarios, for instance in models with general mTOR activation due to TSC mutations, it is not obvious whether alterations in morphology and functions of astrocytes are a result of mTOR dysregulation within astrocytes themselves or if mTOR dysregulation in the surrounding cells and tissues affect astrocytes. Furthermore, astrocytic homeostasis depends on neuronal mTOR activity. Deletion of Raptor in murine neurons inhibits mTORC1 signaling and reduces neuronal fibroblast growth factor 2 release, which causes enhanced astrogliosis [<xref ref-type="bibr" rid="CR84">84</xref>]. This underlines the influence of the signaling status of the surrounding tissue on the properties of astrocytes and complicates the assessment of direct and indirect metabolic effects in diseases such as TSC. On the other hand, astrocytes activated by oxygen-glucose-deprivation / reoxygenation directly influence mTOR signaling in neurons via the release of exosomes containing nicotinamide phosphoribosyltransferase [<xref ref-type="bibr" rid="CR85">85</xref>]. The resulting increase in neuronal autophagy improves the outcome of neuronal injury during acute ischemic stroke [<xref ref-type="bibr" rid="CR85">85</xref>]. Taken together, mTOR signaling in astrocytes is part of a complex signaling network within these cells, but also closely interconnected with signaling and functions of the other cell types of the brain. However, these interdependencies and their functional relevance are currently not well understood and future studies need to shed light on the details of these relationships.</p></sec><sec id="Sec5" sec-type="conclusion"><title>Conclusion</title><p id="Par18">Although the mTOR signaling pathway is mainly known for its role as a regulator of energy metabolism, its balanced activity has a major impact on healthy development and homeostasis in the brain. Due to its multiple interactions with different receptors, ligands, and other signaling pathways, the mTOR pathway is a central and crucial signaling pathway affecting numerous functions in astrocytes; however, its physiological functions and regulation awaits further investigation. In pathophysiology, dysregulated mTOR signaling not only affects the morphology, metabolism and functionality of individual cell types in the brain, it also significantly influences the development, morphology and functionality of the CNS. This often results in serious neurological disorders, such as epilepsy and brain tumors. A better understanding of the influence of this signaling pathway on functions of astrocytes and other brain cell types will contribute to a better understanding of brain physiology and brain disorders and might provide the basis for the development of novel therapy approaches.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author Contributions</title><p>Conceptualization: L.H. and J.H.; Funding acquisition: J.H.; Visualization: L.H.; Writing&#x02013; original draft: L.H.; Writing - review &#x00026; editing: L.H. and J.H.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL.</p><p>Work in the authors&#x02019; laboratory was supported by the Deutsche Forschungsgemeinschaft (DFG; priority program 1757, grant number HI 1414/6&#x02009;&#x02212;&#x02009;1; grant number HI 1414/7&#x02009;&#x02212;&#x02009;1). Open Access funding enabled and organized by Projekt DEAL.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing Interests</title><p id="Par19">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>W-S</given-names></name><name><surname>Allen</surname><given-names>NJ</given-names></name><name><surname>Eroglu</surname><given-names>C</given-names></name></person-group><article-title>Astrocytes control synapse formation, function, and elimination</article-title><source>Cold Spring Harb Perspect Biol</source><year>2015</year><volume>7</volume><fpage>a020370</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a020370</pub-id><pub-id pub-id-type="pmid">25663667</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Chung W-S, Allen NJ, Eroglu C (2015) Astrocytes control synapse formation, function, and elimination. Cold Spring Harb Perspect Biol 7:a020370. 10.1101/cshperspect.a020370<pub-id pub-id-type="pmid">25663667</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Kol</surname><given-names>A</given-names></name><name><surname>Goshen</surname><given-names>I</given-names></name></person-group><article-title>The memory orchestra: the role of astrocytes and oligodendrocytes in parallel to neurons</article-title><source>Curr Opin Neurobiol</source><year>2021</year><volume>67</volume><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2020.10.022</pub-id><pub-id pub-id-type="pmid">33260057</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Kol A, Goshen I (2021) The memory orchestra: the role of astrocytes and oligodendrocytes in parallel to neurons. Curr Opin Neurobiol 67:131&#x02013;137. 10.1016/j.conb.2020.10.022<pub-id pub-id-type="pmid">33260057</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Cabezas</surname><given-names>R</given-names></name><name><surname>Avila</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>J</given-names></name><name><surname>El-Bach&#x000e1;</surname><given-names>RS</given-names></name><name><surname>B&#x000e1;ez</surname><given-names>E</given-names></name><name><surname>Garc&#x000ed;a-Segura</surname><given-names>LM</given-names></name><name><surname>Jurado Coronel</surname><given-names>JC</given-names></name><name><surname>Capani</surname><given-names>F</given-names></name><name><surname>Cardona-Gomez</surname><given-names>GP</given-names></name><name><surname>Barreto</surname><given-names>GE</given-names></name></person-group><article-title>Astrocytic modulation of blood brain barrier: perspectives on Parkinson&#x02019;s disease</article-title><source>Front Cell Neurosci</source><year>2014</year><volume>8</volume><fpage>211</fpage><pub-id pub-id-type="doi">10.3389/fncel.2014.00211</pub-id><pub-id pub-id-type="pmid">25136294</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Cabezas R, Avila M, Gonzalez J, El-Bach&#x000e1; RS, B&#x000e1;ez E, Garc&#x000ed;a-Segura LM, Jurado Coronel JC, Capani F, Cardona-Gomez GP, Barreto GE (2014) Astrocytic modulation of blood brain barrier: perspectives on Parkinson&#x02019;s disease. Front Cell Neurosci 8:211. 10.3389/fncel.2014.00211<pub-id pub-id-type="pmid">25136294</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Bohmbach</surname><given-names>K</given-names></name><name><surname>Henneberger</surname><given-names>C</given-names></name><name><surname>Hirrlinger</surname><given-names>J</given-names></name></person-group><article-title>Astrocytes in memory formation and maintenance</article-title><source>Essays Biochem</source><year>2022</year><volume>67</volume><fpage>107</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1042/EBC20220091</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Bohmbach K, Henneberger C, Hirrlinger J (2022) Astrocytes in memory formation and maintenance. Essays Biochem 67:107&#x02013;117. 10.1042/EBC20220091</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Hirrlinger</surname><given-names>J</given-names></name><name><surname>Nimmerjahn</surname><given-names>A</given-names></name></person-group><article-title>A perspective on astrocyte regulation of neural circuit function and animal behavior</article-title><source>Glia</source><year>2022</year><volume>70</volume><fpage>1554</fpage><lpage>1580</lpage><pub-id pub-id-type="doi">10.1002/glia.24168</pub-id><pub-id pub-id-type="pmid">35297525</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Hirrlinger J, Nimmerjahn A (2022) A perspective on astrocyte regulation of neural circuit function and animal behavior. Glia 70:1554&#x02013;1580. 10.1002/glia.24168<pub-id pub-id-type="pmid">35297525</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;hler</surname><given-names>S</given-names></name><name><surname>Winkler</surname><given-names>U</given-names></name><name><surname>Junge</surname><given-names>T</given-names></name><name><surname>Lippmann</surname><given-names>K</given-names></name><name><surname>Eilers</surname><given-names>J</given-names></name><name><surname>Hirrlinger</surname><given-names>J</given-names></name></person-group><article-title>Gray and white matter astrocytes differ in basal metabolism but respond similarly to neuronal activity</article-title><source>Glia</source><year>2023</year><volume>71</volume><fpage>229</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1002/glia.24268</pub-id><pub-id pub-id-type="pmid">36063073</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">K&#x000f6;hler S, Winkler U, Junge T, Lippmann K, Eilers J, Hirrlinger J (2023) Gray and white matter astrocytes differ in basal metabolism but respond similarly to neuronal activity. Glia 71:229&#x02013;244. 10.1002/glia.24268<pub-id pub-id-type="pmid">36063073</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Hasel</surname><given-names>P</given-names></name><name><surname>Aisenberg</surname><given-names>WH</given-names></name><name><surname>Bennett</surname><given-names>FC</given-names></name><name><surname>Liddelow</surname><given-names>SA</given-names></name></person-group><article-title>Molecular and metabolic heterogeneity of astrocytes and microglia</article-title><source>Cell Metabol</source><year>2023</year><volume>35</volume><fpage>555</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2023.03.006</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Hasel P, Aisenberg WH, Bennett FC, Liddelow SA (2023) Molecular and metabolic heterogeneity of astrocytes and microglia. Cell Metabol 35:555&#x02013;570. 10.1016/j.cmet.2023.03.006</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Kostuk EW, Cai J, Iacovitti L (2019) Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson&#x02019;s disease models in culture. Glia 67:1542&#x02013;1557. 10.1002/glia.23627</mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Ben Haim</surname><given-names>L</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name></person-group><article-title>Functional diversity of astrocytes in neural circuit regulation</article-title><source>Nat Rev Neurosci</source><year>2017</year><volume>18</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/nrn.2016.159</pub-id><pub-id pub-id-type="pmid">27904142</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Ben Haim L, Rowitch DH (2017) Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci 18:31&#x02013;41. 10.1038/nrn.2016.159<pub-id pub-id-type="pmid">27904142</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>MG</given-names></name></person-group><article-title>Astrocyte heterogeneity and interactions with local neural circuits</article-title><source>Essays Biochem</source><year>2023</year><volume>67</volume><fpage>93</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1042/EBC20220136</pub-id><pub-id pub-id-type="pmid">36748397</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Holt MG (2023) Astrocyte heterogeneity and interactions with local neural circuits. Essays Biochem 67:93&#x02013;106. 10.1042/EBC20220136<pub-id pub-id-type="pmid">36748397</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>John Lin</surname><given-names>CC</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Hatcher</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>TW</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Carlson</surname><given-names>J</given-names></name><name><surname>Weston</surname><given-names>MC</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Mohila</surname><given-names>CA</given-names></name><name><surname>Ahmed</surname><given-names>N</given-names></name><name><surname>Patel</surname><given-names>AJ</given-names></name><name><surname>Arenkiel</surname><given-names>BR</given-names></name><name><surname>Noebels</surname><given-names>JL</given-names></name><name><surname>Creighton</surname><given-names>CJ</given-names></name><name><surname>Deneen</surname><given-names>B</given-names></name></person-group><article-title>Identification of diverse astrocyte populations and their malignant analogs</article-title><source>Nat Neurosci</source><year>2017</year><volume>20</volume><fpage>396</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1038/nn.4493</pub-id><pub-id pub-id-type="pmid">28166219</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">John Lin CC, Yu K, Hatcher A, Huang TW, Lee HK, Carlson J, Weston MC, Chen F, Zhang Y, Zhu W, Mohila CA, Ahmed N, Patel AJ, Arenkiel BR, Noebels JL, Creighton CJ, Deneen B (2017) Identification of diverse astrocyte populations and their malignant analogs. Nat Neurosci 20:396&#x02013;405. 10.1038/nn.4493<pub-id pub-id-type="pmid">28166219</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Khakh</surname><given-names>BS</given-names></name><name><surname>Deneen</surname><given-names>B</given-names></name></person-group><article-title>The Emerging Nature of Astrocyte Diversity</article-title><source>Annu Rev Neurosci</source><year>2019</year><volume>42</volume><fpage>187</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-070918-050443</pub-id><pub-id pub-id-type="pmid">31283899</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Khakh BS, Deneen B (2019) The Emerging Nature of Astrocyte Diversity. Annu Rev Neurosci 42:187&#x02013;207. 10.1146/annurev-neuro-070918-050443<pub-id pub-id-type="pmid">31283899</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Bonvento</surname><given-names>G</given-names></name><name><surname>Bola&#x000f1;os</surname><given-names>JP</given-names></name></person-group><article-title>Astrocyte-neuron metabolic cooperation shapes brain activity</article-title><source>Cell Metabol</source><year>2021</year><volume>33</volume><fpage>1546</fpage><lpage>1564</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2021.07.006</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Bonvento G, Bola&#x000f1;os JP (2021) Astrocyte-neuron metabolic cooperation shapes brain activity. Cell Metabol 33:1546&#x02013;1564. 10.1016/j.cmet.2021.07.006</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Mergenthaler</surname><given-names>P</given-names></name><name><surname>Lindauer</surname><given-names>U</given-names></name><name><surname>Dienel</surname><given-names>GA</given-names></name><name><surname>Meisel</surname><given-names>A</given-names></name></person-group><article-title>Sugar for the brain: the role of glucose in physiological and pathological brain function</article-title><source>Trends Neurosci</source><year>2013</year><volume>36</volume><fpage>587</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2013.07.001</pub-id><pub-id pub-id-type="pmid">23968694</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Mergenthaler P, Lindauer U, Dienel GA, Meisel A (2013) Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci 36:587&#x02013;597. 10.1016/j.tins.2013.07.001<pub-id pub-id-type="pmid">23968694</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Kreft M, Bak LK, Waagepetersen HS, Schousboe A (2012) Aspects of astrocyte energy metabolism, amino acid neurotransmitter homoeostasis and metabolic compartmentation. ASN Neuro 4:e00086. 10.1042/an20120007</mixed-citation></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>AM</given-names></name><name><surname>Baltan</surname><given-names>TS</given-names></name><name><surname>Ransom</surname><given-names>BR</given-names></name></person-group><article-title>Energy transfer from astrocytes to axons: the role of CNS glycogen</article-title><source>Neurochem Int</source><year>2004</year><volume>45</volume><fpage>529</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2003.11.005</pub-id><pub-id pub-id-type="pmid">15186919</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Brown AM, Baltan TS, Ransom BR (2004) Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem Int 45:529&#x02013;536. 10.1016/j.neuint.2003.11.005<pub-id pub-id-type="pmid">15186919</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>ME</given-names></name><name><surname>Anderson</surname><given-names>DG</given-names></name><name><surname>Hertz</surname><given-names>L</given-names></name></person-group><article-title>Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens</article-title><source>Glia</source><year>2006</year><volume>54</volume><fpage>214</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1002/glia.20377</pub-id><pub-id pub-id-type="pmid">16819764</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Gibbs ME, Anderson DG, Hertz L (2006) Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens. Glia 54:214&#x02013;222. 10.1002/glia.20377<pub-id pub-id-type="pmid">16819764</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Bak</surname><given-names>LK</given-names></name><name><surname>Walls</surname><given-names>AB</given-names></name></person-group><article-title>CrossTalk opposing view: lack of evidence supporting an astrocyte-to-neuron lactate shuttle coupling neuronal activity to glucose utilisation in the brain</article-title><source>J Physiol</source><year>2018</year><volume>596</volume><fpage>351</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1113/JP274945</pub-id><pub-id pub-id-type="pmid">29292507</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Bak LK, Walls AB (2018) CrossTalk opposing view: lack of evidence supporting an astrocyte-to-neuron lactate shuttle coupling neuronal activity to glucose utilisation in the brain. J Physiol 596:351&#x02013;353. 10.1113/JP274945<pub-id pub-id-type="pmid">29292507</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>LF</given-names></name><name><surname>Weber</surname><given-names>B</given-names></name></person-group><article-title>CrossTalk proposal: an important astrocyte-to-neuron lactate shuttle couples neuronal activity to glucose utilisation in the brain</article-title><source>J Physiol</source><year>2018</year><volume>596</volume><fpage>347</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1113/JP274944</pub-id><pub-id pub-id-type="pmid">29292516</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Barros LF, Weber B (2018) CrossTalk proposal: an important astrocyte-to-neuron lactate shuttle couples neuronal activity to glucose utilisation in the brain. J Physiol 596:347&#x02013;350. 10.1113/JP274944<pub-id pub-id-type="pmid">29292516</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Garc&#x000ed;a</surname><given-names>CM</given-names></name><name><surname>Mongeon</surname><given-names>R</given-names></name><name><surname>Lahmann</surname><given-names>C</given-names></name><name><surname>Koveal</surname><given-names>D</given-names></name><name><surname>Zucker</surname><given-names>H</given-names></name><name><surname>Yellen</surname><given-names>G</given-names></name></person-group><article-title>Neuronal stimulation triggers neuronal glycolysis and not Lactate Uptake</article-title><source>Cell Metabol</source><year>2017</year><volume>26</volume><fpage>361</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.06.021</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">D&#x000ed;az-Garc&#x000ed;a CM, Mongeon R, Lahmann C, Koveal D, Zucker H, Yellen G (2017) Neuronal stimulation triggers neuronal glycolysis and not Lactate Uptake. Cell Metabol 26:361&#x02013;374. 10.1016/j.cmet.2017.06.021</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Alberini</surname><given-names>CM</given-names></name><name><surname>Cruz</surname><given-names>E</given-names></name><name><surname>Descalzi</surname><given-names>G</given-names></name><name><surname>Bessi&#x000e8;res</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>V</given-names></name></person-group><article-title>Astrocyte glycogen and lactate: new insights into learning and memory mechanisms</article-title><source>Glia</source><year>2018</year><volume>66</volume><fpage>1244</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.1002/glia.23250</pub-id><pub-id pub-id-type="pmid">29076603</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Alberini CM, Cruz E, Descalzi G, Bessi&#x000e8;res B, Gao V (2018) Astrocyte glycogen and lactate: new insights into learning and memory mechanisms. Glia 66:1244&#x02013;1262. 10.1002/glia.23250<pub-id pub-id-type="pmid">29076603</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Zuend</surname><given-names>M</given-names></name><name><surname>Saab</surname><given-names>AS</given-names></name><name><surname>Wyss</surname><given-names>MT</given-names></name><name><surname>Ferrari</surname><given-names>KD</given-names></name><name><surname>H&#x000f6;sli</surname><given-names>L</given-names></name><name><surname>Looser</surname><given-names>ZJ</given-names></name><name><surname>Stobart</surname><given-names>JL</given-names></name><name><surname>Duran</surname><given-names>J</given-names></name><name><surname>Guinovart</surname><given-names>JJ</given-names></name><name><surname>Barros</surname><given-names>LF</given-names></name><name><surname>Weber</surname><given-names>B</given-names></name></person-group><article-title>Arousal-induced cortical activity triggers lactate release from astrocytes</article-title><source>Nat Metabolism</source><year>2020</year><volume>2</volume><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1038/s42255-020-0170-4</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Zuend M, Saab AS, Wyss MT, Ferrari KD, H&#x000f6;sli L, Looser ZJ, Stobart JL, Duran J, Guinovart JJ, Barros LF, Weber B (2020) Arousal-induced cortical activity triggers lactate release from astrocytes. Nat Metabolism 2:179&#x02013;191. 10.1038/s42255-020-0170-4</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Moncada</surname><given-names>I</given-names></name><name><surname>Lavanco</surname><given-names>G</given-names></name><name><surname>Fundazuri</surname><given-names>UB</given-names></name><name><surname>Bollmohr</surname><given-names>N</given-names></name><name><surname>Mountadem</surname><given-names>S</given-names></name><name><surname>Dalla Tor</surname><given-names>T</given-names></name><name><surname>Hachaguer</surname><given-names>P</given-names></name><name><surname>Julio-Kalajzic</surname><given-names>F</given-names></name><name><surname>Gisquet</surname><given-names>D</given-names></name><name><surname>Serrat</surname><given-names>R</given-names></name><name><surname>Bellocchio</surname><given-names>L</given-names></name><name><surname>Cannich</surname><given-names>A</given-names></name><name><surname>Fortunato-Marsol</surname><given-names>B</given-names></name><name><surname>Nasu</surname><given-names>Y</given-names></name><name><surname>Campbell</surname><given-names>RE</given-names></name><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Cannizzaro</surname><given-names>C</given-names></name><name><surname>Ferreira</surname><given-names>G</given-names></name><name><surname>Bouzier-Sore</surname><given-names>A-K</given-names></name><name><surname>Pellerin</surname><given-names>L</given-names></name><name><surname>Bola&#x000f1;os</surname><given-names>JP</given-names></name><name><surname>Bonvento</surname><given-names>G</given-names></name><name><surname>Barros</surname><given-names>LF</given-names></name><name><surname>Oliet</surname><given-names>SHR</given-names></name><name><surname>Panatier</surname><given-names>A</given-names></name><name><surname>Marsicano</surname><given-names>G</given-names></name></person-group><article-title>A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice</article-title><source>Nat Commun</source><year>2024</year><volume>15</volume><fpage>6842</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-51008-2</pub-id><pub-id pub-id-type="pmid">39122700</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Fern&#x000e1;ndez-Moncada I, Lavanco G, Fundazuri UB, Bollmohr N, Mountadem S, Dalla Tor T, Hachaguer P, Julio-Kalajzic F, Gisquet D, Serrat R, Bellocchio L, Cannich A, Fortunato-Marsol B, Nasu Y, Campbell RE, Drago F, Cannizzaro C, Ferreira G, Bouzier-Sore A-K, Pellerin L, Bola&#x000f1;os JP, Bonvento G, Barros LF, Oliet SHR, Panatier A, Marsicano G (2024) A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice. Nat Commun 15:6842. 10.1038/s41467-024-51008-2<pub-id pub-id-type="pmid">39122700</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Theparambil</surname><given-names>SM</given-names></name><name><surname>Kopach</surname><given-names>O</given-names></name><name><surname>Braga</surname><given-names>A</given-names></name><name><surname>Nizari</surname><given-names>S</given-names></name><name><surname>Hosford</surname><given-names>PS</given-names></name><name><surname>Sagi-Kiss</surname><given-names>V</given-names></name><name><surname>Hadjihambi</surname><given-names>A</given-names></name><name><surname>Konstantinou</surname><given-names>C</given-names></name><name><surname>Esteras</surname><given-names>N</given-names></name><name><surname>Del Gutierrez Arroyo</surname><given-names>A</given-names></name><name><surname>Ackland</surname><given-names>GL</given-names></name><name><surname>Teschemacher</surname><given-names>AG</given-names></name><name><surname>Dale</surname><given-names>N</given-names></name><name><surname>Eckle</surname><given-names>T</given-names></name><name><surname>Andrikopoulos</surname><given-names>P</given-names></name><name><surname>Rusakov</surname><given-names>DA</given-names></name><name><surname>Kasparov</surname><given-names>S</given-names></name><name><surname>Gourine</surname><given-names>AV</given-names></name></person-group><article-title>Adenosine signalling to astrocytes coordinates brain metabolism and function</article-title><source>Nature</source><year>2024</year><volume>632</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1038/s41586-024-07611-w</pub-id><pub-id pub-id-type="pmid">38961289</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Theparambil SM, Kopach O, Braga A, Nizari S, Hosford PS, Sagi-Kiss V, Hadjihambi A, Konstantinou C, Esteras N, Del Gutierrez Arroyo A, Ackland GL, Teschemacher AG, Dale N, Eckle T, Andrikopoulos P, Rusakov DA, Kasparov S, Gourine AV (2024) Adenosine signalling to astrocytes coordinates brain metabolism and function. Nature 632:139&#x02013;146. 10.1038/s41586-024-07611-w<pub-id pub-id-type="pmid">38961289</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Schousboe</surname><given-names>A</given-names></name><name><surname>Waagepetersen</surname><given-names>HS</given-names></name><name><surname>Sonnewald</surname><given-names>U</given-names></name></person-group><article-title>Astrocytic pyruvate carboxylation: Status after 35 years</article-title><source>J Neurosci Res</source><year>2019</year><volume>97</volume><fpage>890</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1002/jnr.24402</pub-id><pub-id pub-id-type="pmid">30801795</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Schousboe A, Waagepetersen HS, Sonnewald U (2019) Astrocytic pyruvate carboxylation: Status after 35 years. J Neurosci Res 97:890&#x02013;896. 10.1002/jnr.24402<pub-id pub-id-type="pmid">30801795</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>AC</given-names></name><name><surname>Drejer</surname><given-names>J</given-names></name><name><surname>Hertz</surname><given-names>L</given-names></name><name><surname>Schousboe</surname><given-names>A</given-names></name></person-group><article-title>Pyruvate carboxylase activity in primary cultures of astrocytes and neurons</article-title><source>J Neurochem</source><year>1983</year><volume>41</volume><fpage>1484</fpage><lpage>1487</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1983.tb00849.x</pub-id><pub-id pub-id-type="pmid">6619879</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Yu AC, Drejer J, Hertz L, Schousboe A (1983) Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J Neurochem 41:1484&#x02013;1487. 10.1111/j.1471-4159.1983.tb00849.x<pub-id pub-id-type="pmid">6619879</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Shank</surname><given-names>RP</given-names></name><name><surname>Bennett</surname><given-names>GS</given-names></name><name><surname>Freytag</surname><given-names>SO</given-names></name><name><surname>Campbell</surname><given-names>GL</given-names></name></person-group><article-title>Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools</article-title><source>Brain Res</source><year>1985</year><volume>329</volume><fpage>364</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(85)90552-9</pub-id><pub-id pub-id-type="pmid">3884090</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Shank RP, Bennett GS, Freytag SO, Campbell GL (1985) Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res 329:364&#x02013;367. 10.1016/0006-8993(85)90552-9<pub-id pub-id-type="pmid">3884090</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Cesar</surname><given-names>M</given-names></name><name><surname>Hamprecht</surname><given-names>B</given-names></name></person-group><article-title>Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase</article-title><source>J Neurochem</source><year>1995</year><volume>64</volume><fpage>2312</fpage><lpage>2318</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.1995.64052312.x</pub-id><pub-id pub-id-type="pmid">7722517</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Cesar M, Hamprecht B (1995) Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase. J Neurochem 64:2312&#x02013;2318. 10.1046/j.1471-4159.1995.64052312.x<pub-id pub-id-type="pmid">7722517</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Hirrlinger</surname><given-names>J</given-names></name><name><surname>Schulz</surname><given-names>JB</given-names></name><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells</article-title><source>J Neurosci Res</source><year>2002</year><volume>69</volume><fpage>318</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1002/jnr.10308</pub-id><pub-id pub-id-type="pmid">12125073</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Hirrlinger J, Schulz JB, Dringen R (2002) Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J Neurosci Res 69:318&#x02013;326. 10.1002/jnr.10308<pub-id pub-id-type="pmid">12125073</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Dringen</surname><given-names>R</given-names></name><name><surname>Hirrlinger</surname><given-names>J</given-names></name></person-group><article-title>Glutathione pathways in the brain</article-title><source>Biol Chem</source><year>2003</year><volume>384</volume><fpage>505</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1515/BC.2003.059</pub-id><pub-id pub-id-type="pmid">12751781</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Dringen R, Hirrlinger J (2003) Glutathione pathways in the brain. Biol Chem 384:505&#x02013;516. 10.1515/BC.2003.059<pub-id pub-id-type="pmid">12751781</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>JV</given-names></name><name><surname>Schousboe</surname><given-names>A</given-names></name><name><surname>Verkhratsky</surname><given-names>A</given-names></name></person-group><article-title>Astrocyte energy and neurotransmitter metabolism in Alzheimer&#x02019;s disease: integration of the glutamate/GABA-glutamine cycle</article-title><source>Prog Neurobiol</source><year>2022</year><volume>217</volume><fpage>102331</fpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2022.102331</pub-id><pub-id pub-id-type="pmid">35872221</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Andersen JV, Schousboe A, Verkhratsky A (2022) Astrocyte energy and neurotransmitter metabolism in Alzheimer&#x02019;s disease: integration of the glutamate/GABA-glutamine cycle. Prog Neurobiol 217:102331. 10.1016/j.pneurobio.2022.102331<pub-id pub-id-type="pmid">35872221</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Bak</surname><given-names>LK</given-names></name><name><surname>Schousboe</surname><given-names>A</given-names></name><name><surname>Waagepetersen</surname><given-names>HS</given-names></name></person-group><article-title>The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer</article-title><source>J Neurochem</source><year>2006</year><volume>98</volume><fpage>641</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.03913.x</pub-id><pub-id pub-id-type="pmid">16787421</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98:641&#x02013;653. 10.1111/j.1471-4159.2006.03913.x<pub-id pub-id-type="pmid">16787421</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>K</given-names></name><name><surname>Kamiya</surname><given-names>T</given-names></name><name><surname>Tsuboi</surname><given-names>T</given-names></name></person-group><article-title>Gliotransmitter release from astrocytes: Functional, Developmental, and pathological implications in the brain</article-title><source>Front Neurosci</source><year>2015</year><volume>9</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3389/fnins.2015.00499</pub-id><pub-id pub-id-type="pmid">25653585</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Harada K, Kamiya T, Tsuboi T (2015) Gliotransmitter release from astrocytes: Functional, Developmental, and pathological implications in the brain. Front Neurosci 9:1&#x02013;9. 10.3389/fnins.2015.00499<pub-id pub-id-type="pmid">25653585</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Angulo</surname><given-names>MC</given-names></name><name><surname>Kozlov</surname><given-names>AS</given-names></name><name><surname>Charpak</surname><given-names>S</given-names></name><name><surname>Audinat</surname><given-names>E</given-names></name></person-group><article-title>Glutamate released from glial cells synchronizes neuronal activity in the hippocampus</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>6920</fpage><lpage>6927</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0473-04.2004</pub-id><pub-id pub-id-type="pmid">15295027</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Angulo MC, Kozlov AS, Charpak S, Audinat E (2004) Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. J Neurosci 24:6920&#x02013;6927. 10.1523/JNEUROSCI.0473-04.2004<pub-id pub-id-type="pmid">15295027</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Perea</surname><given-names>G</given-names></name><name><surname>Araque</surname><given-names>A</given-names></name></person-group><article-title>GLIA modulates synaptic transmission</article-title><source>Brain Res Rev</source><year>2010</year><volume>63</volume><fpage>93</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2009.10.005</pub-id><pub-id pub-id-type="pmid">19896978</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Perea G, Araque A (2010) GLIA modulates synaptic transmission. Brain Res Rev 63:93&#x02013;102. 10.1016/j.brainresrev.2009.10.005<pub-id pub-id-type="pmid">19896978</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>JF</given-names></name><name><surname>Araque</surname><given-names>A</given-names></name></person-group><article-title>Astrocyte regulation of neural circuit activity and network states</article-title><source>Glia</source><year>2022</year><volume>70</volume><fpage>1455</fpage><lpage>1466</lpage><pub-id pub-id-type="doi">10.1002/glia.24178</pub-id><pub-id pub-id-type="pmid">35460131</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Oliveira JF, Araque A (2022) Astrocyte regulation of neural circuit activity and network states. Glia 70:1455&#x02013;1466. 10.1002/glia.24178<pub-id pub-id-type="pmid">35460131</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>K</given-names></name><name><surname>Maruki</surname><given-names>Y</given-names></name><name><surname>Long</surname><given-names>X</given-names></name><name><surname>Yoshino</surname><given-names>K</given-names></name><name><surname>Oshiro</surname><given-names>N</given-names></name><name><surname>Hidayat</surname><given-names>S</given-names></name><name><surname>Tokunaga</surname><given-names>C</given-names></name><name><surname>Avruch</surname><given-names>J</given-names></name><name><surname>Yonezawa</surname><given-names>K</given-names></name></person-group><article-title>Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action</article-title><source>Cell</source><year>2002</year><volume>110</volume><fpage>177</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(02)00833-4</pub-id><pub-id pub-id-type="pmid">12150926</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J, Yonezawa K (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110:177&#x02013;189. 10.1016/s0092-8674(02)00833-4<pub-id pub-id-type="pmid">12150926</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Saxton</surname><given-names>RA</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>mTOR Signaling in Growth, Metabolism, and Disease</article-title><source>Cell</source><year>2017</year><volume>168</volume><fpage>960</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.02.004</pub-id><pub-id pub-id-type="pmid">28283069</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Saxton RA, Sabatini DM (2017) mTOR Signaling in Growth, Metabolism, and Disease. Cell 168:960&#x02013;976. 10.1016/j.cell.2017.02.004<pub-id pub-id-type="pmid">28283069</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Simcox</surname><given-names>J</given-names></name><name><surname>Lamming</surname><given-names>DW</given-names></name></person-group><article-title>The central moTOR of metabolism</article-title><source>Dev Cell</source><year>2022</year><volume>57</volume><fpage>691</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2022.02.024</pub-id><pub-id pub-id-type="pmid">35316619</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Simcox J, Lamming DW (2022) The central moTOR of metabolism. Dev Cell 57:691&#x02013;706. 10.1016/j.devcel.2022.02.024<pub-id pub-id-type="pmid">35316619</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Panwar</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Bhatt</surname><given-names>M</given-names></name><name><surname>Tonk</surname><given-names>RK</given-names></name><name><surname>Azizov</surname><given-names>S</given-names></name><name><surname>Raza</surname><given-names>AS</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Garg</surname><given-names>M</given-names></name></person-group><article-title>Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease</article-title><source>Signal Transduct Target Ther</source><year>2023</year><volume>8</volume><fpage>375</fpage><pub-id pub-id-type="doi">10.1038/s41392-023-01608-z</pub-id><pub-id pub-id-type="pmid">37779156</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, Sengupta S, Kumar D, Garg M (2023) Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther 8:375. 10.1038/s41392-023-01608-z<pub-id pub-id-type="pmid">37779156</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Jacinto</surname><given-names>E</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>R&#x000fc;egg</surname><given-names>MA</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><article-title>Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive</article-title><source>Nat Cell Biol</source><year>2004</year><volume>6</volume><fpage>1122</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1038/ncb1183</pub-id><pub-id pub-id-type="pmid">15467718</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Jacinto E, Loewith R, Schmidt A, Lin S, R&#x000fc;egg MA, Hall A, Hall MN (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6:1122&#x02013;1128. 10.1038/ncb1183<pub-id pub-id-type="pmid">15467718</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Arriola Apelo</surname><given-names>SI</given-names></name><name><surname>Lamming</surname><given-names>DW</given-names></name></person-group><article-title>mTORC2 puts its shoulder to Krebs&#x02019; wheel</article-title><source>Mol Cell</source><year>2016</year><volume>63</volume><fpage>723</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.08.016</pub-id><pub-id pub-id-type="pmid">27588599</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Arriola Apelo SI, Lamming DW (2016) mTORC2 puts its shoulder to Krebs&#x02019; wheel. Mol Cell 63:723&#x02013;725. 10.1016/j.molcel.2016.08.016<pub-id pub-id-type="pmid">27588599</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>O-GlcNAcylation of Raptor transduces glucose signals to mTORC1</article-title><source>Mol Cell</source><year>2023</year><volume>83</volume><fpage>3027</fpage><lpage>3040e11</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2023.07.011</pub-id><pub-id pub-id-type="pmid">37541260</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Xu C, Pan X, Wang D, Guan Y, Yang W, Chen X, Liu Y (2023) O-GlcNAcylation of Raptor transduces glucose signals to mTORC1. Mol Cell 83:3027&#x02013;3040e11. 10.1016/j.molcel.2023.07.011<pub-id pub-id-type="pmid">37541260</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Houde</surname><given-names>VP</given-names></name><name><surname>Br&#x000fb;l&#x000e9;</surname><given-names>S</given-names></name><name><surname>Festuccia</surname><given-names>WT</given-names></name><name><surname>Blanchard</surname><given-names>P-G</given-names></name><name><surname>Bellmann</surname><given-names>K</given-names></name><name><surname>Deshaies</surname><given-names>Y</given-names></name><name><surname>Marette</surname><given-names>A</given-names></name></person-group><article-title>Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue</article-title><source>Diabetes</source><year>2010</year><volume>59</volume><fpage>1338</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.2337/db09-1324</pub-id><pub-id pub-id-type="pmid">20299475</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Houde VP, Br&#x000fb;l&#x000e9; S, Festuccia WT, Blanchard P-G, Bellmann K, Deshaies Y, Marette A (2010) Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 59:1338&#x02013;1348. 10.2337/db09-1324<pub-id pub-id-type="pmid">20299475</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Chellappa</surname><given-names>K</given-names></name><name><surname>Brinkman</surname><given-names>JA</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Morrison</surname><given-names>M</given-names></name><name><surname>Alotaibi</surname><given-names>MI</given-names></name><name><surname>Carbajal</surname><given-names>KA</given-names></name><name><surname>Alhadeff</surname><given-names>AL</given-names></name><name><surname>Perron</surname><given-names>IJ</given-names></name><name><surname>Yao</surname><given-names>R</given-names></name><name><surname>Purdy</surname><given-names>CS</given-names></name><name><surname>DeFelice</surname><given-names>DM</given-names></name><name><surname>Wakai</surname><given-names>MH</given-names></name><name><surname>Tomasiewicz</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>E</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Arriola Apelo</surname><given-names>SI</given-names></name><name><surname>Puglielli</surname><given-names>L</given-names></name><name><surname>Betley</surname><given-names>JN</given-names></name><name><surname>Paschos</surname><given-names>GK</given-names></name><name><surname>Baur</surname><given-names>JA</given-names></name><name><surname>Lamming</surname><given-names>DW</given-names></name></person-group><article-title>Hypothalamic mTORC2 is essential for metabolic health and longevity</article-title><source>Aging Cell</source><year>2019</year><volume>18</volume><fpage>e13014</fpage><pub-id pub-id-type="doi">10.1111/acel.13014</pub-id><pub-id pub-id-type="pmid">31373126</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Chellappa K, Brinkman JA, Mukherjee S, Morrison M, Alotaibi MI, Carbajal KA, Alhadeff AL, Perron IJ, Yao R, Purdy CS, DeFelice DM, Wakai MH, Tomasiewicz J, Lin A, Meyer E, Peng Y, Arriola Apelo SI, Puglielli L, Betley JN, Paschos GK, Baur JA, Lamming DW (2019) Hypothalamic mTORC2 is essential for metabolic health and longevity. Aging Cell 18:e13014. 10.1111/acel.13014<pub-id pub-id-type="pmid">31373126</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Lindner</surname><given-names>J</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Yuan</surname><given-names>W</given-names></name><name><surname>Magnuson</surname><given-names>MA</given-names></name></person-group><article-title>Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size</article-title><source>Diabetes</source><year>2011</year><volume>60</volume><fpage>827</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.2337/db10-1194</pub-id><pub-id pub-id-type="pmid">21266327</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Gu Y, Lindner J, Kumar A, Yuan W, Magnuson MA (2011) Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes 60:827&#x02013;837. 10.2337/db10-1194<pub-id pub-id-type="pmid">21266327</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000fc;vel</surname><given-names>K</given-names></name><name><surname>Yecies</surname><given-names>JL</given-names></name><name><surname>Menon</surname><given-names>S</given-names></name><name><surname>Raman</surname><given-names>P</given-names></name><name><surname>Lipovsky</surname><given-names>AI</given-names></name><name><surname>Souza</surname><given-names>AL</given-names></name><name><surname>Triantafellow</surname><given-names>E</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Gorski</surname><given-names>R</given-names></name><name><surname>Cleaver</surname><given-names>S</given-names></name><name><surname>Vander Heiden</surname><given-names>MG</given-names></name><name><surname>MacKeigan</surname><given-names>JP</given-names></name><name><surname>Finan</surname><given-names>PM</given-names></name><name><surname>Clish</surname><given-names>CB</given-names></name><name><surname>Murphy</surname><given-names>LO</given-names></name><name><surname>Manning</surname><given-names>BD</given-names></name></person-group><article-title>Activation of a metabolic gene regulatory network downstream of mTOR complex 1</article-title><source>Mol Cell</source><year>2010</year><volume>39</volume><fpage>171</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.06.022</pub-id><pub-id pub-id-type="pmid">20670887</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">D&#x000fc;vel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, Vander Heiden MG, MacKeigan JP, Finan PM, Clish CB, Murphy LO, Manning BD (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39:171&#x02013;183. 10.1016/j.molcel.2010.06.022<pub-id pub-id-type="pmid">20670887</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Kliegman</surname><given-names>JI</given-names></name><name><surname>Fiedler</surname><given-names>D</given-names></name><name><surname>Ryan</surname><given-names>CJ</given-names></name><name><surname>Xu</surname><given-names>Y-F</given-names></name><name><surname>Su</surname><given-names>X-Y</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Caccese</surname><given-names>MC</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Shales</surname><given-names>M</given-names></name><name><surname>Rabinowitz</surname><given-names>JD</given-names></name><name><surname>Krogan</surname><given-names>NJ</given-names></name><name><surname>Shokat</surname><given-names>KM</given-names></name></person-group><article-title>Chemical genetics of rapamycin-insensitive TORC2 in S. Cerevisiae</article-title><source>Cell Rep</source><year>2013</year><volume>5</volume><fpage>1725</fpage><lpage>1736</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.11.040</pub-id><pub-id pub-id-type="pmid">24360963</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Kliegman JI, Fiedler D, Ryan CJ, Xu Y-F, Su X-Y, Thomas D, Caccese MC, Cheng A, Shales M, Rabinowitz JD, Krogan NJ, Shokat KM (2013) Chemical genetics of rapamycin-insensitive TORC2 in S. cerevisiae. Cell Rep 5:1725&#x02013;1736. 10.1016/j.celrep.2013.11.040<pub-id pub-id-type="pmid">24360963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Buj</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>C-W</given-names></name><name><surname>Dahl</surname><given-names>ES</given-names></name><name><surname>Leon</surname><given-names>KE</given-names></name><name><surname>Kuskovsky</surname><given-names>R</given-names></name><name><surname>Maglakelidze</surname><given-names>N</given-names></name><name><surname>Navaratnarajah</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Doan</surname><given-names>MT</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Zaleski</surname><given-names>M</given-names></name><name><surname>Kutzler</surname><given-names>L</given-names></name><name><surname>Lacko</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name><name><surname>Gowda</surname><given-names>R</given-names></name><name><surname>Robertson</surname><given-names>GP</given-names></name><name><surname>Warrick</surname><given-names>JI</given-names></name><name><surname>Herlyn</surname><given-names>M</given-names></name><name><surname>Imamura</surname><given-names>Y</given-names></name><name><surname>Kimball</surname><given-names>SR</given-names></name><name><surname>DeGraff</surname><given-names>DJ</given-names></name><name><surname>Snyder</surname><given-names>NW</given-names></name><name><surname>Aird</surname><given-names>KM</given-names></name></person-group><article-title>Suppression of p16 induces mTORC1-Mediated nucleotide metabolic reprogramming</article-title><source>Cell Rep</source><year>2019</year><volume>28</volume><fpage>1971</fpage><lpage>1980e8</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.07.084</pub-id><pub-id pub-id-type="pmid">31433975</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Buj R, Chen C-W, Dahl ES, Leon KE, Kuskovsky R, Maglakelidze N, Navaratnarajah M, Zhang G, Doan MT, Jiang H, Zaleski M, Kutzler L, Lacko H, Lu Y, Mills GB, Gowda R, Robertson GP, Warrick JI, Herlyn M, Imamura Y, Kimball SR, DeGraff DJ, Snyder NW, Aird KM (2019) Suppression of p16 induces mTORC1-Mediated nucleotide metabolic reprogramming. Cell Rep 28:1971&#x02013;1980e8. 10.1016/j.celrep.2019.07.084<pub-id pub-id-type="pmid">31433975</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Haghighat</surname><given-names>A</given-names></name><name><surname>Mader</surname><given-names>S</given-names></name><name><surname>Pause</surname><given-names>A</given-names></name><name><surname>Sonenberg</surname><given-names>N</given-names></name></person-group><article-title>Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E</article-title><source>EMBO J</source><year>1995</year><volume>14</volume><fpage>5701</fpage><lpage>5709</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb00257.x</pub-id><pub-id pub-id-type="pmid">8521827</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Haghighat A, Mader S, Pause A, Sonenberg N (1995) Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J 14:5701&#x02013;5709. 10.1002/j.1460-2075.1995.tb00257.x<pub-id pub-id-type="pmid">8521827</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Raught</surname><given-names>B</given-names></name><name><surname>Peiretti</surname><given-names>F</given-names></name><name><surname>Gingras</surname><given-names>A-C</given-names></name><name><surname>Livingstone</surname><given-names>M</given-names></name><name><surname>Shahbazian</surname><given-names>D</given-names></name><name><surname>Mayeur</surname><given-names>GL</given-names></name><name><surname>Polakiewicz</surname><given-names>RD</given-names></name><name><surname>Sonenberg</surname><given-names>N</given-names></name><name><surname>Hershey</surname><given-names>JWB</given-names></name></person-group><article-title>Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases</article-title><source>EMBO J</source><year>2004</year><volume>23</volume><fpage>1761</fpage><lpage>1769</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600193</pub-id><pub-id pub-id-type="pmid">15071500</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Raught B, Peiretti F, Gingras A-C, Livingstone M, Shahbazian D, Mayeur GL, Polakiewicz RD, Sonenberg N, Hershey JWB (2004) Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 23:1761&#x02013;1769. 10.1038/sj.emboj.7600193<pub-id pub-id-type="pmid">15071500</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Holz</surname><given-names>MK</given-names></name><name><surname>Ballif</surname><given-names>BA</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Blenis</surname><given-names>J</given-names></name></person-group><article-title>mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events</article-title><source>Cell</source><year>2005</year><volume>123</volume><fpage>569</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.10.024</pub-id><pub-id pub-id-type="pmid">16286006</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Holz MK, Ballif BA, Gygi SP, Blenis J (2005) mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123:569&#x02013;580. 10.1016/j.cell.2005.10.024<pub-id pub-id-type="pmid">16286006</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>T</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>5575</fpage><lpage>5584</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.15.5575-5584.2002</pub-id><pub-id pub-id-type="pmid">12101249</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Peng T, Golub TR, Sabatini DM (2002) The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol Cell Biol 22:5575&#x02013;5584. 10.1128/MCB.22.15.5575-5584.2002<pub-id pub-id-type="pmid">12101249</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Albuquerque</surname><given-names>CP</given-names></name><name><surname>Braas</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Villa</surname><given-names>GR</given-names></name><name><surname>Bi</surname><given-names>J</given-names></name><name><surname>Ikegami</surname><given-names>S</given-names></name><name><surname>Masui</surname><given-names>K</given-names></name><name><surname>Gini</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Gahman</surname><given-names>TC</given-names></name><name><surname>Shiau</surname><given-names>AK</given-names></name><name><surname>Cloughesy</surname><given-names>TF</given-names></name><name><surname>Christofk</surname><given-names>HR</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>K-L</given-names></name><name><surname>Mischel</surname><given-names>PS</given-names></name></person-group><article-title>mTORC2 regulates amino acid metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT</article-title><source>Mol Cell</source><year>2017</year><volume>67</volume><fpage>128</fpage><lpage>138e7</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.05.030</pub-id><pub-id pub-id-type="pmid">28648777</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Gu Y, Albuquerque CP, Braas D, Zhang W, Villa GR, Bi J, Ikegami S, Masui K, Gini B, Yang H, Gahman TC, Shiau AK, Cloughesy TF, Christofk HR, Zhou H, Guan K-L, Mischel PS (2017) mTORC2 regulates amino acid metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT. Mol Cell 67:128&#x02013;138e7. 10.1016/j.molcel.2017.05.030<pub-id pub-id-type="pmid">28648777</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Crino</surname><given-names>PB</given-names></name></person-group><article-title>The mTOR signalling cascade: paving new roads to cure neurological disease</article-title><source>Nat Rev Neurol</source><year>2016</year><volume>12</volume><fpage>379</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2016.81</pub-id><pub-id pub-id-type="pmid">27340022</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Crino PB (2016) The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol 12:379&#x02013;392. 10.1038/nrneurol.2016.81<pub-id pub-id-type="pmid">27340022</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>LH</given-names></name><name><surname>Mahadeo</surname><given-names>T</given-names></name><name><surname>Bordey</surname><given-names>A</given-names></name></person-group><article-title>mTOR hyperactivity levels influence the severity of Epilepsy and Associated Neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia</article-title><source>J Neurosci</source><year>2019</year><volume>39</volume><fpage>2762</fpage><lpage>2773</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2260-18.2019</pub-id><pub-id pub-id-type="pmid">30700531</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Nguyen LH, Mahadeo T, Bordey A (2019) mTOR hyperactivity levels influence the severity of Epilepsy and Associated Neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia. J Neurosci 39:2762&#x02013;2773. 10.1523/JNEUROSCI.2260-18.2019<pub-id pub-id-type="pmid">30700531</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>CW</given-names></name><name><surname>Verhaak</surname><given-names>RGW</given-names></name><name><surname>McKenna</surname><given-names>A</given-names></name><name><surname>Campos</surname><given-names>B</given-names></name><name><surname>Noushmehr</surname><given-names>H</given-names></name><name><surname>Salama</surname><given-names>SR</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Chakravarty</surname><given-names>D</given-names></name><name><surname>Sanborn</surname><given-names>JZ</given-names></name><name><surname>Berman</surname><given-names>SH</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Bernard</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>C-J</given-names></name><name><surname>Genovese</surname><given-names>G</given-names></name><name><surname>Shmulevich</surname><given-names>I</given-names></name><name><surname>Barnholtz-Sloan</surname><given-names>J</given-names></name><name><surname>Zou</surname><given-names>L</given-names></name><name><surname>Vegesna</surname><given-names>R</given-names></name><name><surname>Shukla</surname><given-names>SA</given-names></name><name><surname>Ciriello</surname><given-names>G</given-names></name><name><surname>Yung</surname><given-names>WK</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Sougnez</surname><given-names>C</given-names></name><name><surname>Mikkelsen</surname><given-names>T</given-names></name><name><surname>Aldape</surname><given-names>K</given-names></name><name><surname>Bigner</surname><given-names>DD</given-names></name><name><surname>van Meir</surname><given-names>EG</given-names></name><name><surname>Prados</surname><given-names>M</given-names></name><name><surname>Sloan</surname><given-names>A</given-names></name><name><surname>Black</surname><given-names>KL</given-names></name><name><surname>Eschbacher</surname><given-names>J</given-names></name><name><surname>Finocchiaro</surname><given-names>G</given-names></name><name><surname>Friedman</surname><given-names>W</given-names></name><name><surname>Andrews</surname><given-names>DW</given-names></name><name><surname>Guha</surname><given-names>A</given-names></name><name><surname>Iacocca</surname><given-names>M</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>BP</given-names></name><name><surname>Foltz</surname><given-names>G</given-names></name><name><surname>Myers</surname><given-names>J</given-names></name><name><surname>Weisenberger</surname><given-names>DJ</given-names></name><name><surname>Penny</surname><given-names>R</given-names></name><name><surname>Kucherlapati</surname><given-names>R</given-names></name><name><surname>Perou</surname><given-names>CM</given-names></name><name><surname>Hayes</surname><given-names>DN</given-names></name><name><surname>Gibbs</surname><given-names>R</given-names></name><name><surname>Marra</surname><given-names>M</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name><name><surname>Lander</surname><given-names>E</given-names></name><name><surname>Spellman</surname><given-names>P</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name><name><surname>Weinstein</surname><given-names>J</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>Laird</surname><given-names>PW</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Chin</surname><given-names>L</given-names></name></person-group><article-title>The somatic genomic landscape of glioblastoma</article-title><source>Cell</source><year>2013</year><volume>155</volume><fpage>462</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.09.034</pub-id><pub-id pub-id-type="pmid">24120142</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Brennan CW, Verhaak RGW, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu C-J, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O&#x02019;Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L (2013) The somatic genomic landscape of glioblastoma. Cell 155:462&#x02013;477. 10.1016/j.cell.2013.09.034<pub-id pub-id-type="pmid">24120142</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Walling</surname><given-names>J</given-names></name><name><surname>Kotliarov</surname><given-names>Y</given-names></name><name><surname>Center</surname><given-names>A</given-names></name><name><surname>Steed</surname><given-names>ME</given-names></name><name><surname>Ahn</surname><given-names>SJ</given-names></name><name><surname>Rosenblum</surname><given-names>M</given-names></name><name><surname>Mikkelsen</surname><given-names>T</given-names></name><name><surname>Zenklusen</surname><given-names>JC</given-names></name><name><surname>Fine</surname><given-names>HA</given-names></name></person-group><article-title>Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas</article-title><source>Mol Cancer Res</source><year>2008</year><volume>6</volume><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-07-0280</pub-id><pub-id pub-id-type="pmid">18184972</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Li A, Walling J, Kotliarov Y, Center A, Steed ME, Ahn SJ, Rosenblum M, Mikkelsen T, Zenklusen JC, Fine HA (2008) Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Mol Cancer Res 6:21&#x02013;30. 10.1158/1541-7786.MCR-07-0280<pub-id pub-id-type="pmid">18184972</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Rud&#x000e0;</surname><given-names>R</given-names></name><name><surname>Bruno</surname><given-names>F</given-names></name><name><surname>Pellerino</surname><given-names>A</given-names></name></person-group><article-title>Epilepsy in gliomas: recent insights into risk factors and molecular pathways</article-title><source>Curr Opin Neurol</source><year>2023</year><volume>36</volume><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1097/WCO.0000000000001214</pub-id><pub-id pub-id-type="pmid">37865836</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Rud&#x000e0; R, Bruno F, Pellerino A (2023) Epilepsy in gliomas: recent insights into risk factors and molecular pathways. Curr Opin Neurol 36:557&#x02013;563. 10.1097/WCO.0000000000001214<pub-id pub-id-type="pmid">37865836</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Long</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>R</given-names></name></person-group><article-title>HABP2 encapsulated by Peripheral Blood-Derived Exosomes suppresses astrocyte autophagy to Exacerbate Neuroinflammatory Injury in mice with ischemic stroke</article-title><source>ACS Chem Neurosci</source><year>2023</year><volume>14</volume><fpage>2347</fpage><lpage>2361</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.3c00089</pub-id><pub-id pub-id-type="pmid">37294185</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Luo H, Huang Q, Huang D, Liu C, Long X, Tang R (2023) HABP2 encapsulated by Peripheral Blood-Derived Exosomes suppresses astrocyte autophagy to Exacerbate Neuroinflammatory Injury in mice with ischemic stroke. ACS Chem Neurosci 14:2347&#x02013;2361. 10.1021/acschemneuro.3c00089<pub-id pub-id-type="pmid">37294185</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Xiang</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name></person-group><article-title>SerpinA3N attenuates ischemic stroke injury by reducing apoptosis and neuroinflammation</article-title><source>CNS Neurosci Ther</source><year>2022</year><volume>28</volume><fpage>566</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1111/cns.13776</pub-id><pub-id pub-id-type="pmid">34897996</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Zhang Y, Chen Q, Chen D, Zhao W, Wang H, Yang M, Xiang Z, Yuan H (2022) SerpinA3N attenuates ischemic stroke injury by reducing apoptosis and neuroinflammation. CNS Neurosci Ther 28:566&#x02013;579. 10.1111/cns.13776<pub-id pub-id-type="pmid">34897996</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Ichisaka</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Oshiro</surname><given-names>N</given-names></name><name><surname>Hara</surname><given-names>K</given-names></name><name><surname>Edenhofer</surname><given-names>F</given-names></name><name><surname>Kiyama</surname><given-names>H</given-names></name><name><surname>Yonezawa</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name></person-group><article-title>mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>6710</fpage><lpage>6718</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.15.6710-6718.2004</pub-id><pub-id pub-id-type="pmid">15254238</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Murakami M, Ichisaka T, Maeda M, Oshiro N, Hara K, Edenhofer F, Kiyama H, Yonezawa K, Yamanaka S (2004) mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 24:6710&#x02013;6718. 10.1128/MCB.24.15.6710-6718.2004<pub-id pub-id-type="pmid">15254238</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Land</surname><given-names>SC</given-names></name><name><surname>Scott</surname><given-names>CL</given-names></name><name><surname>Walker</surname><given-names>D</given-names></name></person-group><article-title>mTOR signalling, embryogenesis and the control of lung development</article-title><source>Semin Cell Dev Biol</source><year>2014</year><volume>36</volume><fpage>68</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.09.023</pub-id><pub-id pub-id-type="pmid">25289569</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Land SC, Scott CL, Walker D (2014) mTOR signalling, embryogenesis and the control of lung development. Semin Cell Dev Biol 36:68&#x02013;78. 10.1016/j.semcdb.2014.09.023<pub-id pub-id-type="pmid">25289569</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Curatolo</surname><given-names>P</given-names></name><name><surname>Specchio</surname><given-names>N</given-names></name><name><surname>Aronica</surname><given-names>E</given-names></name></person-group><article-title>Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy</article-title><source>Lancet Neurol</source><year>2022</year><volume>21</volume><fpage>843</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(22)00213-7</pub-id><pub-id pub-id-type="pmid">35963265</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Curatolo P, Specchio N, Aronica E (2022) Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy. Lancet Neurol 21:843&#x02013;856. 10.1016/S1474-4422(22)00213-7<pub-id pub-id-type="pmid">35963265</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Aronica</surname><given-names>E</given-names></name><name><surname>Specchio</surname><given-names>N</given-names></name><name><surname>Luinenburg</surname><given-names>MJ</given-names></name><name><surname>Curatolo</surname><given-names>P</given-names></name></person-group><article-title>Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy</article-title><source>Brain</source><year>2023</year><volume>146</volume><fpage>2694</fpage><lpage>2710</lpage><pub-id pub-id-type="doi">10.1093/brain/awad048</pub-id><pub-id pub-id-type="pmid">36806388</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Aronica E, Specchio N, Luinenburg MJ, Curatolo P (2023) Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy. Brain 146:2694&#x02013;2710. 10.1093/brain/awad048<pub-id pub-id-type="pmid">36806388</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmer</surname><given-names>TS</given-names></name><name><surname>Broekaart</surname><given-names>DWM</given-names></name><name><surname>Gruber</surname><given-names>V-E</given-names></name><name><surname>van Vliet</surname><given-names>EA</given-names></name><name><surname>M&#x000fc;hlebner</surname><given-names>A</given-names></name><name><surname>Aronica</surname><given-names>E</given-names></name></person-group><article-title>Tuberous sclerosis complex as Disease Model for investigating mTOR-Related Gliopathy during Epileptogenesis</article-title><source>Front Neurol</source><year>2020</year><volume>11</volume><fpage>1028</fpage><pub-id pub-id-type="doi">10.3389/fneur.2020.01028</pub-id><pub-id pub-id-type="pmid">33041976</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Zimmer TS, Broekaart DWM, Gruber V-E, van Vliet EA, M&#x000fc;hlebner A, Aronica E (2020) Tuberous sclerosis complex as Disease Model for investigating mTOR-Related Gliopathy during Epileptogenesis. Front Neurol 11:1028. 10.3389/fneur.2020.01028<pub-id pub-id-type="pmid">33041976</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Luinenburg</surname><given-names>MJ</given-names></name><name><surname>Scheper</surname><given-names>M</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>FNF</given-names></name><name><surname>Anink</surname><given-names>JJ</given-names></name><name><surname>van Hecke</surname><given-names>W</given-names></name><name><surname>Korshunova</surname><given-names>I</given-names></name><name><surname>Jansen</surname><given-names>FE</given-names></name><name><surname>Riney</surname><given-names>K</given-names></name><name><surname>van Eijsden</surname><given-names>P</given-names></name><name><surname>Gosselaar</surname><given-names>P</given-names></name><name><surname>Mills</surname><given-names>JD</given-names></name><name><surname>Kalf</surname><given-names>RS</given-names></name><name><surname>Zimmer</surname><given-names>TS</given-names></name><name><surname>Broekaart</surname><given-names>DWM</given-names></name><name><surname>Khodosevich</surname><given-names>K</given-names></name><name><surname>Aronica</surname><given-names>E</given-names></name><name><surname>M&#x000fc;hlebner</surname><given-names>A</given-names></name></person-group><article-title>Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytes</article-title><source>Front Cell Neurosci</source><year>2023</year><volume>17</volume><fpage>1284394</fpage><pub-id pub-id-type="doi">10.3389/fncel.2023.1284394</pub-id><pub-id pub-id-type="pmid">38089143</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Luinenburg MJ, Scheper M, S&#x000f8;rensen FNF, Anink JJ, van Hecke W, Korshunova I, Jansen FE, Riney K, van Eijsden P, Gosselaar P, Mills JD, Kalf RS, Zimmer TS, Broekaart DWM, Khodosevich K, Aronica E, M&#x000fc;hlebner A (2023) Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytes. Front Cell Neurosci 17:1284394. 10.3389/fncel.2023.1284394<pub-id pub-id-type="pmid">38089143</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Sosunov</surname><given-names>AA</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Weiner</surname><given-names>HL</given-names></name><name><surname>Mikell</surname><given-names>CB</given-names></name><name><surname>Goodman</surname><given-names>RR</given-names></name><name><surname>Crino</surname><given-names>PD</given-names></name><name><surname>McKhann</surname><given-names>GM</given-names></name></person-group><article-title>Tuberous sclerosis: a primary pathology of astrocytes?</article-title><source>Epilepsia 49 Suppl</source><year>2008</year><volume>2</volume><fpage>53</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01493.x</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Sosunov AA, Wu X, Weiner HL, Mikell CB, Goodman RR, Crino PD, McKhann GM (2008) Tuberous sclerosis: a primary pathology of astrocytes? Epilepsia 49 Suppl 2:53&#x02013;62. 10.1111/j.1528-1167.2008.01493.x</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Talos</surname><given-names>DM</given-names></name><name><surname>Kwiatkowski</surname><given-names>DJ</given-names></name><name><surname>Cordero</surname><given-names>K</given-names></name><name><surname>Black</surname><given-names>PM</given-names></name><name><surname>Jensen</surname><given-names>FE</given-names></name></person-group><article-title>Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers</article-title><source>Ann Neurol</source><year>2008</year><volume>63</volume><fpage>454</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1002/ana.21342</pub-id><pub-id pub-id-type="pmid">18350576</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE (2008) Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol 63:454&#x02013;465. 10.1002/ana.21342<pub-id pub-id-type="pmid">18350576</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Sosunov</surname><given-names>AA</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>McGovern</surname><given-names>RA</given-names></name><name><surname>Coughlin</surname><given-names>DG</given-names></name><name><surname>Mikell</surname><given-names>CB</given-names></name><name><surname>Goodman</surname><given-names>RR</given-names></name><name><surname>McKhann</surname><given-names>GM</given-names></name></person-group><article-title>The mTOR pathway is activated in glial cells in mesial temporal sclerosis</article-title><source>Epilepsia 53 Suppl</source><year>2012</year><volume>1</volume><fpage>78</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03478.x</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Sosunov AA, Wu X, McGovern RA, Coughlin DG, Mikell CB, Goodman RR, McKhann GM (2012) The mTOR pathway is activated in glial cells in mesial temporal sclerosis. Epilepsia 53 Suppl 1:78&#x02013;86. 10.1111/j.1528-1167.2012.03478.x</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>AC</given-names></name><name><surname>Ashley</surname><given-names>DM</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>GY</given-names></name><name><surname>Malinzak</surname><given-names>M</given-names></name><name><surname>Friedman</surname><given-names>HS</given-names></name><name><surname>Khasraw</surname><given-names>M</given-names></name></person-group><article-title>Management of glioblastoma: state of the art and future directions</article-title><source>CA Cancer J Clin</source><year>2020</year><volume>70</volume><fpage>299</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.3322/caac.21613</pub-id><pub-id pub-id-type="pmid">32478924</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Tan AC, Ashley DM, L&#x000f3;pez GY, Malinzak M, Friedman HS, Khasraw M (2020) Management of glioblastoma: state of the art and future directions. CA Cancer J Clin 70:299&#x02013;312. 10.3322/caac.21613<pub-id pub-id-type="pmid">32478924</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Neftel</surname><given-names>C</given-names></name><name><surname>Laffy</surname><given-names>J</given-names></name><name><surname>Filbin</surname><given-names>MG</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Shore</surname><given-names>ME</given-names></name><name><surname>Rahme</surname><given-names>GJ</given-names></name><name><surname>Richman</surname><given-names>AR</given-names></name><name><surname>Silverbush</surname><given-names>D</given-names></name><name><surname>Shaw</surname><given-names>ML</given-names></name><name><surname>Hebert</surname><given-names>CM</given-names></name><name><surname>Dewitt</surname><given-names>J</given-names></name><name><surname>Gritsch</surname><given-names>S</given-names></name><name><surname>Perez</surname><given-names>EM</given-names></name><name><surname>Gonzalez Castro</surname><given-names>LN</given-names></name><name><surname>Lan</surname><given-names>X</given-names></name><name><surname>Druck</surname><given-names>N</given-names></name><name><surname>Rodman</surname><given-names>C</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><name><surname>Kaplan</surname><given-names>A</given-names></name><name><surname>Bertalan</surname><given-names>MS</given-names></name><name><surname>Small</surname><given-names>J</given-names></name><name><surname>Pelton</surname><given-names>K</given-names></name><name><surname>Becker</surname><given-names>S</given-names></name><name><surname>Bonal</surname><given-names>D</given-names></name><name><surname>Nguyen</surname><given-names>Q-D</given-names></name><name><surname>Servis</surname><given-names>RL</given-names></name><name><surname>Fung</surname><given-names>JM</given-names></name><name><surname>Mylvaganam</surname><given-names>R</given-names></name><name><surname>Mayr</surname><given-names>L</given-names></name><name><surname>Gojo</surname><given-names>J</given-names></name><name><surname>Haberler</surname><given-names>C</given-names></name><name><surname>Geyeregger</surname><given-names>R</given-names></name><name><surname>Czech</surname><given-names>T</given-names></name><name><surname>Slavc</surname><given-names>I</given-names></name><name><surname>Nahed</surname><given-names>BV</given-names></name><name><surname>Curry</surname><given-names>WT</given-names></name><name><surname>Carter</surname><given-names>BS</given-names></name><name><surname>Wakimoto</surname><given-names>H</given-names></name><name><surname>Brastianos</surname><given-names>PK</given-names></name><name><surname>Batchelor</surname><given-names>TT</given-names></name><name><surname>Stemmer-Rachamimov</surname><given-names>A</given-names></name><name><surname>Martinez-Lage</surname><given-names>M</given-names></name><name><surname>Frosch</surname><given-names>MP</given-names></name><name><surname>Stamenkovic</surname><given-names>I</given-names></name><name><surname>Riggi</surname><given-names>N</given-names></name><name><surname>Rheinbay</surname><given-names>E</given-names></name><name><surname>Monje</surname><given-names>M</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Cahill</surname><given-names>DP</given-names></name><name><surname>Patel</surname><given-names>AP</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name><name><surname>Verma</surname><given-names>IM</given-names></name><name><surname>Ligon</surname><given-names>KL</given-names></name><name><surname>Louis</surname><given-names>DN</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Tirosh</surname><given-names>I</given-names></name><name><surname>Suv&#x000e0;</surname><given-names>ML</given-names></name></person-group><article-title>An Integrative Model of Cellular States, plasticity, and Genetics for Glioblastoma</article-title><source>Cell</source><year>2019</year><volume>178</volume><fpage>835</fpage><lpage>849e21</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.06.024</pub-id><pub-id pub-id-type="pmid">31327527</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez EM, Gonzalez Castro LN, Lan X, Druck N, Rodman C, Dionne D, Kaplan A, Bertalan MS, Small J, Pelton K, Becker S, Bonal D, Nguyen Q-D, Servis RL, Fung JM, Mylvaganam R, Mayr L, Gojo J, Haberler C, Geyeregger R, Czech T, Slavc I, Nahed BV, Curry WT, Carter BS, Wakimoto H, Brastianos PK, Batchelor TT, Stemmer-Rachamimov A, Martinez-Lage M, Frosch MP, Stamenkovic I, Riggi N, Rheinbay E, Monje M, Rozenblatt-Rosen O, Cahill DP, Patel AP, Hunter T, Verma IM, Ligon KL, Louis DN, Regev A, Bernstein BE, Tirosh I, Suv&#x000e0; ML (2019) An Integrative Model of Cellular States, plasticity, and Genetics for Glioblastoma. Cell 178:835&#x02013;849e21. 10.1016/j.cell.2019.06.024<pub-id pub-id-type="pmid">31327527</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenbarth</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>YA</given-names></name></person-group><article-title>Glioblastoma heterogeneity at single cell resolution</article-title><source>Oncogene</source><year>2023</year><volume>42</volume><fpage>2155</fpage><lpage>2165</lpage><pub-id pub-id-type="doi">10.1038/s41388-023-02738-y</pub-id><pub-id pub-id-type="pmid">37277603</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Eisenbarth D, Wang YA (2023) Glioblastoma heterogeneity at single cell resolution. Oncogene 42:2155&#x02013;2165. 10.1038/s41388-023-02738-y<pub-id pub-id-type="pmid">37277603</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">Colardo M, Segatto M, Di Bartolomeo S (2021) Targeting RTK-PI3K-mTOR Axis in Gliomas: an update. Int J Mol Sci 22. 10.3390/ijms22094899</mixed-citation></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Carbonneau</surname><given-names>M</given-names></name><name><surname>Gagn&#x000e9;</surname><given-names>M</given-names></name><name><surname>Lalonde</surname><given-names>L</given-names></name><name><surname>Germain</surname><given-names>M-E</given-names></name><name><surname>Motorina</surname><given-names>M-A</given-names></name><name><surname>Guiot</surname><given-names>A</given-names></name><name><surname>Secco</surname><given-names>M-C</given-names></name><name><surname>Vincent</surname><given-names>B</given-names></name><name><surname>Tumber</surname><given-names>EE</given-names></name><name><surname>Hulea</surname><given-names>A</given-names></name><name><surname>Bergeman</surname><given-names>L</given-names></name><name><surname>Oppermann</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>U</given-names></name><name><surname>Laplante</surname><given-names>RG</given-names></name><name><surname>Topisirovic</surname><given-names>M</given-names></name><name><surname>Petrecca</surname><given-names>I</given-names></name><name><surname>Huot</surname><given-names>K</given-names></name><name><surname>Mallette</surname><given-names>M-&#x000c9;</given-names></name></person-group><article-title>The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><fpage>12700</fpage><pub-id pub-id-type="doi">10.1038/ncomms12700</pub-id><pub-id pub-id-type="pmid">27624942</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Carbonneau M, Gagn&#x000e9; M, Lalonde L, Germain M-E, Motorina M-A, Guiot A, Secco M-C, Vincent B, Tumber EE, Hulea A, Bergeman L, Oppermann J, Jones U, Laplante RG, Topisirovic M, Petrecca I, Huot K, Mallette M-&#x000c9; FA (2016) The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat Commun 7:12700. 10.1038/ncomms12700<pub-id pub-id-type="pmid">27624942</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Mortazavi</surname><given-names>A</given-names></name><name><surname>Fayed</surname><given-names>I</given-names></name><name><surname>Bachani</surname><given-names>M</given-names></name><name><surname>Dowdy</surname><given-names>T</given-names></name><name><surname>Jahanipour</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Owotade</surname><given-names>J</given-names></name><name><surname>Walbridge</surname><given-names>S</given-names></name><name><surname>Inati</surname><given-names>SK</given-names></name><name><surname>Steiner</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Gilbert</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>CZ</given-names></name><name><surname>Larion</surname><given-names>M</given-names></name><name><surname>Maric</surname><given-names>D</given-names></name><name><surname>Ksendzovsky</surname><given-names>A</given-names></name><name><surname>Zaghloul</surname><given-names>KA</given-names></name></person-group><article-title>IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation</article-title><source>Neuro Oncol</source><year>2022</year><volume>24</volume><fpage>1423</fpage><lpage>1435</lpage><pub-id pub-id-type="doi">10.1093/neuonc/noac003</pub-id><pub-id pub-id-type="pmid">34994387</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Mortazavi A, Fayed I, Bachani M, Dowdy T, Jahanipour J, Khan A, Owotade J, Walbridge S, Inati SK, Steiner J, Wu J, Gilbert M, Yang CZ, Larion M, Maric D, Ksendzovsky A, Zaghloul KA (2022) IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation. Neuro Oncol 24:1423&#x02013;1435. 10.1093/neuonc/noac003<pub-id pub-id-type="pmid">34994387</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Ess</surname><given-names>KC</given-names></name><name><surname>Uhlmann</surname><given-names>EJ</given-names></name><name><surname>Jansen</surname><given-names>LA</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Crino</surname><given-names>PB</given-names></name><name><surname>Mennerick</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>KA</given-names></name><name><surname>Gutmann</surname><given-names>DH</given-names></name></person-group><article-title>Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model</article-title><source>Ann Neurol</source><year>2003</year><volume>54</volume><fpage>251</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1002/ana.10648</pub-id><pub-id pub-id-type="pmid">12891680</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Wong M, Ess KC, Uhlmann EJ, Jansen LA, Li W, Crino PB, Mennerick S, Yamada KA, Gutmann DH (2003) Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol 54:251&#x02013;256. 10.1002/ana.10648<pub-id pub-id-type="pmid">12891680</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Jiao</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Shao</surname><given-names>J</given-names></name></person-group><article-title>Marrow mesenchymal stem cell-derived exosomes Upregulate Astrocytic Glutamate Transporter-1 expression via miR-124/mTOR pathway against oxygen-glucose Deprivation/Reperfusion Injury</article-title><source>J Integr Neurosci</source><year>2023</year><volume>22</volume><fpage>144</fpage><pub-id pub-id-type="doi">10.31083/j.jin2206144</pub-id><pub-id pub-id-type="pmid">38176931</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Huang W, Fan Y, Jiang C, Jiao J, Ji W, Huang H, Shao J (2023) Marrow mesenchymal stem cell-derived exosomes Upregulate Astrocytic Glutamate Transporter-1 expression via miR-124/mTOR pathway against oxygen-glucose Deprivation/Reperfusion Injury. J Integr Neurosci 22:144. 10.31083/j.jin2206144<pub-id pub-id-type="pmid">38176931</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>S</given-names></name><name><surname>Ji</surname><given-names>Y-F</given-names></name></person-group><article-title>Upregulation of glutamate transporter 1 by mTOR/Akt pathway in astrocyte culture during oxygen-glucose deprivation and reoxygenation</article-title><source>Exp Brain Res</source><year>2023</year><volume>241</volume><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1007/s00221-022-06514-4</pub-id><pub-id pub-id-type="pmid">36436003</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Li M, Yu J, Deng H, Xie S, Li Q, Zhao Y, Yin S, Ji Y-F (2023) Upregulation of glutamate transporter 1 by mTOR/Akt pathway in astrocyte culture during oxygen-glucose deprivation and reoxygenation. Exp Brain Res 241:201&#x02013;209. 10.1007/s00221-022-06514-4<pub-id pub-id-type="pmid">36436003</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>L-H</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Gutmann</surname><given-names>DH</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name></person-group><article-title>Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex</article-title><source>Ann Neurol</source><year>2008</year><volume>63</volume><fpage>444</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1002/ana.21331</pub-id><pub-id pub-id-type="pmid">18389497</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Zeng L-H, Xu L, Gutmann DH, Wong M (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63:444&#x02013;453. 10.1002/ana.21331<pub-id pub-id-type="pmid">18389497</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>L-H</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name></person-group><article-title>Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex</article-title><source>Neurobiol Dis</source><year>2009</year><volume>34</volume><fpage>291</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2009.01.010</pub-id><pub-id pub-id-type="pmid">19385061</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Xu L, Zeng L-H, Wong M (2009) Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex. Neurobiol Dis 34:291&#x02013;299. 10.1016/j.nbd.2009.01.010<pub-id pub-id-type="pmid">19385061</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Romagnolo</surname><given-names>A</given-names></name><name><surname>Dematteis</surname><given-names>G</given-names></name><name><surname>Scheper</surname><given-names>M</given-names></name><name><surname>Luinenburg</surname><given-names>MJ</given-names></name><name><surname>M&#x000fc;hlebner</surname><given-names>A</given-names></name><name><surname>van Hecke</surname><given-names>W</given-names></name><name><surname>Manfredi</surname><given-names>M</given-names></name><name><surname>de Giorgis</surname><given-names>V</given-names></name><name><surname>Reano</surname><given-names>S</given-names></name><name><surname>Filigheddu</surname><given-names>N</given-names></name><name><surname>Bortolotto</surname><given-names>V</given-names></name><name><surname>Tapella</surname><given-names>L</given-names></name><name><surname>Anink</surname><given-names>JJ</given-names></name><name><surname>Fran&#x000e7;ois</surname><given-names>L</given-names></name><name><surname>Dedeurwaerdere</surname><given-names>S</given-names></name><name><surname>Mills</surname><given-names>JD</given-names></name><name><surname>Genazzani</surname><given-names>AA</given-names></name><name><surname>Lim</surname><given-names>D</given-names></name><name><surname>Aronica</surname><given-names>E</given-names></name></person-group><article-title>Astroglial calcium signaling and homeostasis in tuberous sclerosis complex</article-title><source>Acta Neuropathol</source><year>2024</year><volume>147</volume><fpage>48</fpage><pub-id pub-id-type="doi">10.1007/s00401-024-02711-3</pub-id><pub-id pub-id-type="pmid">38418708</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Romagnolo A, Dematteis G, Scheper M, Luinenburg MJ, M&#x000fc;hlebner A, van Hecke W, Manfredi M, de Giorgis V, Reano S, Filigheddu N, Bortolotto V, Tapella L, Anink JJ, Fran&#x000e7;ois L, Dedeurwaerdere S, Mills JD, Genazzani AA, Lim D, Aronica E (2024) Astroglial calcium signaling and homeostasis in tuberous sclerosis complex. Acta Neuropathol 147:48. 10.1007/s00401-024-02711-3<pub-id pub-id-type="pmid">38418708</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>L-H</given-names></name><name><surname>Rensing</surname><given-names>NR</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name></person-group><article-title>The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy</article-title><source>J Neurosci</source><year>2009</year><volume>29</volume><fpage>6964</fpage><lpage>6972</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0066-09.2009</pub-id><pub-id pub-id-type="pmid">19474323</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Zeng L-H, Rensing NR, Wong M (2009) The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 29:6964&#x02013;6972. 10.1523/JNEUROSCI.0066-09.2009<pub-id pub-id-type="pmid">19474323</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>K-Y</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Zou</surname><given-names>Z-P</given-names></name><name><surname>Yang</surname><given-names>C-L</given-names></name><name><surname>Tan</surname><given-names>K</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>T-M</given-names></name><name><surname>Bai</surname><given-names>X-C</given-names></name></person-group><article-title>Neuronal mTORC1 is required for maintaining the nonreactive state of astrocytes</article-title><source>J Biol Chem</source><year>2017</year><volume>292</volume><fpage>100</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.744482</pub-id><pub-id pub-id-type="pmid">27895121</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Zhang Y, Xu S, Liang K-Y, Li K, Zou Z-P, Yang C-L, Tan K, Cao X, Jiang Y, Gao T-M, Bai X-C (2017) Neuronal mTORC1 is required for maintaining the nonreactive state of astrocytes. J Biol Chem 292:100&#x02013;111. 10.1074/jbc.M116.744482<pub-id pub-id-type="pmid">27895121</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>R</given-names></name><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Gu</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name></person-group><article-title>Astrocyte-derived exosomal nicotinamide phosphoribosyltransferase (Nampt) ameliorates ischemic stroke injury by targeting AMPK/mTOR signaling to induce autophagy</article-title><source>Cell Death Dis</source><year>2022</year><volume>13</volume><fpage>1057</fpage><pub-id pub-id-type="doi">10.1038/s41419-022-05454-9</pub-id><pub-id pub-id-type="pmid">36539418</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Deng Y, Duan R, Ding W, Gu Q, Liu M, Zhou J, Sun J, Zhu J (2022) Astrocyte-derived exosomal nicotinamide phosphoribosyltransferase (Nampt) ameliorates ischemic stroke injury by targeting AMPK/mTOR signaling to induce autophagy. Cell Death Dis 13:1057. 10.1038/s41419-022-05454-9<pub-id pub-id-type="pmid">36539418</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>